Click2PrintAE®, an end-to-end digital workflow for 3D printed ocular prosthetics

Click2PrintAE®，3D 打印义眼的端到端数字工作流程

• 批准号: 10071306
• 金额: $ 26.45万
• 依托单位: OCUPEYE LIMITED
• 依托单位国家: 英国
• 项目类别: Collaborative R&D
• 财政年份: 2023
• 资助国家: 英国
• 起止时间: 2023 至 无数据
• 项目状态: 未结题
• 来源: https://gtr.ukri.org/projects?ref=10071306
• 关键词: Click2PrintAE; end; digital; workflow; 3D

Incorporated in 2016, Ocupeye are a UK-based SME with an innovative, visionary team of assistive devices innovators led by design, engineering, and business experts. Our strong ambition to drive positive change within the healthcare industry has led us on a journey to create a 3D printing process for prosthetic eyes that not only reduces hospital costs and labour time, but prioritises patient comfort, satisfaction, and prosthetic fit.Over 8 million people worldwide and 70k in the UK wear a prosthetic eye \[Moorfields Eye Charity\]. Despite technological advancements elsewhere in healthcare, the current process to supply ocular prosthetics to patients has remained largely unchanged for over 70 years, with ocular prosthetics currently moulded, shaped, painted, and fitted individually by hand with techniques from the 1950s. The process is invasive and often traumatic for patients, particularly for children, with alginate injections required to make wax patterns for patient's eye shapes. Prosthetics are then hand-painted, assembled, and polished, which is time-consuming and requires highly skilled resource. Waiting list time been exacerbated by COVID-19, with waiting list numbers for elective care increased from 4.4 million to 6 million people \[NHS Delivery Plan\]. This greatly impacts patient care, satisfaction, and overall quality of life.To address these issues, Ocupeye will bring to market the world's first end-to-end digital process for the 3D printing and manufacture of prosthetic eyes. The process will be non-invasive and no-touch to patients and significantly reduce the extortionate waiting list time from 60 weeks to a 3-week turnaround, whilst delivering a much-needed, innovative life sciences product into healthcare more quickly and effectively.

Ocupeye 成立于 2016 年，是一家总部位于英国的中小企业，拥有一支由设计、工程和业务专家领导的辅助设备创新者组成的创新且富有远见的团队。我们怀着推动医疗保健行业积极变革的强烈雄心，引领我们踏上为义眼创建 3D 打印流程的旅程，不仅降低医院成本和劳动时间，而且优先考虑患者的舒适度、满意度和假肢贴合度。超过 800 万世界各地的人们和英国的 7 万人佩戴了义眼“[Moorfields Eye Charity”]。尽管医疗保健领域的其他技术取得了进步，但目前为患者提供眼部假肢的流程在 70 多年来基本保持不变，眼部假体目前采用 20 世纪 50 年代的技术单独手工模制、成型、涂漆和安装。该过程对患者（尤其是儿童）来说是侵入性的，通常会造成创伤，需要注射藻酸盐来制作适合患者眼睛形状的蜡模。然后对假肢进行手绘、组装和抛光，这既耗时又需要高技能的资源。 COVID-19 加剧了等候名单时间，选择性护理的等候名单人数从 440 万人增加到 600 万人 [NHS 交付计划]。这极大地影响了患者护理、满意度和整体生活质量。为了解决这些问题，Ocupeye 将向市场推出世界上第一个用于 3D 打印和制造假眼的端到端数字流程。该过程将是非侵入性的，不接触患者，并将等待时间从 60 周显着缩短至 3 周，同时更快、更有效地向医疗保健领域提供急需的创新生命科学产品。